NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
- Research and development, 2025
- $37M
- YoY, 2025
- +19.0%
- 5-year CAGR
- +35.1%
- 10-year CAGR
- +24.3%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $37M | +19.0% |
| 2024 | $31M | +14.1% |
| 2023 | $27M | −9.9% |
| 2022 | $30M | +38.6% |
| 2021 | $22M | +165.8% |
| 2020 | $8.2M | −3.0% |
| 2019 | $8.5M | +182.8% |
| 2018 | $3.0M | −17.5% |
| 2017 | $3.6M | −21.8% |
| 2016 | $4.6M | +10.7% |
| 2015 | $4.2M | +56.1% |
| 2014 | $2.7M | +10.2% |
| 2013 | $2.4M | +7.0% |
| 2012 | $2.3M | +320.1% |
| 2011 | $543K | — |